Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

cvs pharmacy - titanium dioxide 4.9%, zinc oxide 4.7% - sunscreen • helps prevent sunburn • if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun - ​​on damaged or broken skin - rash occurs.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

cvs pharmacy - titanium dioxide 4.9%, zinc oxide 4.7% - sunscreen • helps prevent sunburn • if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun - ​​on damaged or broken skin - rash occurs.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - zinc oxide -

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

cvs pharmacy - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun - on damaged or broken skin. - rash occurs.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

cvs pharmacy - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see  directions ), decreases the risk of skin cancer and early skin aging caused by the sun • on damaged or broken skin. • rash occurs.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

ross laboratories aust pty ltd - zinc oxide, quantity: 50 mg/g; octocrylene, quantity: 100 mg/g; 4-methylbenzylidene camphor, quantity: 40 mg/g; butyl methoxydibenzoylmethane, quantity: 50 mg/g - lotion - excipient ingredients: hydroxyacetophenone; phenoxyethanol; edetate sodium; dl-alpha-tocopheryl acetate; aloe vera; purified water; colloidal anhydrous silica; isopropyl palmitate; liquid paraffin; dried magnesium sulfate; microcrystalline wax; hydrogenated castor oil; peg-30 dipolyhydroxystearate; cyclomethicone - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - atosiban (as acetate) - premature birth - other gynecologicals - atosiban is indicated to delay imminent pre-term birth in pregnant adult women with:regular uterine contractions of at least 30 seconds’ duration at a rate of ≥ 4 per 30 minutes;a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%;a gestational age from 24 until 33 completed weeks;a normal foetal heart rate.

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

sun pharmaceutical industries (europe) b.v. - bortezomib - multiple myeloma - antineoplastic agents - bortezomib sun as monotherapy or in combination with pegylated liposomal doxorubicin or dexamethasone is indicated for the treatment of adult patients with progressive multiple myeloma who have received at least 1 prior therapy and who have already undergone or are unsuitable for haematopoietic stem cell transplantation.bortezomib sun in combination with melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib sun in combination with dexamethasone, or with dexamethasone and thalidomide, is indicated for the induction treatment of adult patients with previously untreated multiple myeloma who are eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib sun in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - levetiracetam - epilepsy - other antiepileptics - levetiracetam sun is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam sun is indicated as adjunctive therapy:in the treatment of partial-onset seizures with or without secondary generalisation in adults and children from four years of age with epilepsy;in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy;in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.levetiracetam sun concentrate is an alternative for patients when oral administration is temporarily not feasible.

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - temozolomide - glioma; glioblastoma - antineoplastic agents - temozolomide sun is indicated for the treatment of:adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy (rt) and subsequently as monotherapy treatment;children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.